Cutaneous ulceration as a sign of methotrexate toxicity

European Journal of Dermatology

Volumn 11, Issue 5, 2001, Pages 450-452

  Del Pozo, J ^a   Martinez W ^a   Garcia Silva J ^a   Almagro, M ^a   Pena Penabad C ^a   Fonseca, E ^a  

^a HOSPITAL JUAN CANALEJO   (Spain)

Author keywords

Cutaneous ulceration; Methotrexate

Indexed keywords

INDOMETACIN; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PSEUDOMONIC ACID;

ADULT; ARTHRITIS; ARTICLE; CASE REPORT; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG MECHANISM; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN TISSUE; RISK FACTOR; SKIN BIOPSY; SKIN ULCER;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS; FEMALE; HUMANS; METHOTREXATE; SKIN ULCER;

EID: 0034868989     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. The mechanism of action of methotrexate
2. Methotrexate inhibits polymorphonuclear leucocyte chemotaxis in psoriasis
3. Methotrexate therapy of psoriasis: Differential sensitivity of proliferating lymphoid and epithelial cells to the cytotoxic and growth-inhibitory effects of methotrexate
4. The remarkable spectrum of methotrexate toxicities
5. Methotrexate side effects
6. Cutaneous ulceration: An unusual sign of methotrexate toxicity
7. Pharmacology and pharmacokinetics of methotrexate in rheumatic disease
8. Erosion of psoriatic plaques: An early sign of methotrexate toxicity
9. Low-dose methotrexate to treat erythrodermic cutaneous T cell lymphoma: Results in twenty-nine patients